Basilard BioTech

Trinidad & Tobago
California, Couva-Tabaquite-Talparo, Trinidad and Tobago

Company profile

Basilard BioTech company profile

Basilard BioTech features a technology platform that transforms the rapidly growing cell-based therapies market. Cell and Gene Therapies (CGT) have immense potential to address unmet clinical needs by leveraging the power and diversity of cell functions. They offer the best hope for finding solutions to prevailing diseases that affect and kill millions of people.

Business identity

Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0-$1M
Founded
2019-01-01, Year

Headquarters

Country code
TT
Continent
North America

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
3
Total equity funding
$500,000
Last funding
Seed / 2022-02-01
Last equity funding
Seed
Investors
5
Lead investors
1
Founders
3
Articles
8

Founders and investors

Founders

Brynley LeeChris BallasMasaru Rao

Lead investors

BioBrit

Investors

BioBritCasdin CapitalPaladin Capital GroupSeedFolioSunstone Management